Table of Contents

2019-2024 Global Levothyroxine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Levothyroxine Consumption 2014-2024
  • 2.1.2 Levothyroxine Consumption CAGR by Region
• 2.2 Levothyroxine Segment by Type
  • 2.2.1 Slice in solid
  • 2.2.2 In bottles for injection
• 2.3 Levothyroxine Consumption by Type
  • 2.3.1 Global Levothyroxine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Levothyroxine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Levothyroxine Sale Price by Type (2014-2019)
• 2.4 Levothyroxine Segment by Application
  • 2.4.1 Hospitals
  • 2.4.2 Chemist's shops
  • 2.4.3 Other medical institutions
• 2.5 Levothyroxine Consumption by Application
  • 2.5.1 Global Levothyroxine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Levothyroxine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Levothyroxine Sale Price by Application (2014-2019)

3 Global Levothyroxine by Players

• 3.1 Global Levothyroxine Sales Market Share by Players
  • 3.1.1 Global Levothyroxine Sales by Players (2017-2019)
  • 3.1.2 Global Levothyroxine Sales Market Share by Players (2017-2019)
• 3.2 Global Levothyroxine Revenue Market Share by Players
  • 3.2.1 Global Levothyroxine Revenue by Players (2017-2019)
  • 3.2.2 Global Levothyroxine Revenue Market Share by Players (2017-2019)
• 3.3 Global Levothyroxine Sale Price by Players
• 3.4 Global Levothyroxine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Levothyroxine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Levothyroxine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Levothyroxine by Regions

• 4.1 Levothyroxine by Regions
  • 4.1.1 Global Levothyroxine Consumption by Regions
  • 4.1.2 Global Levothyroxine Value by Regions
• 4.2 Americas Levothyroxine Consumption Growth
• 4.3 APAC Levothyroxine Consumption Growth
• 4.4 Europe Levothyroxine Consumption Growth
• 4.5 Middle East & Africa Levothyroxine Consumption Growth

5 Americas

• 5.1 Americas Levothyroxine Consumption by Countries
  • 5.1.1 Americas Levothyroxine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Levothyroxine Value by Countries (2014-2019)
• 5.2 Americas Levothyroxine Consumption by Type
• 5.3 Americas Levothyroxine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Levothyroxine Consumption by Countries
  • 6.1.1 APAC Levothyroxine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Levothyroxine Value by Countries (2014-2019)
• 6.2 APAC Levothyroxine Consumption by Type
• 6.3 APAC Levothyroxine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Levothyroxine by Countries
  • 7.1.1 Europe Levothyroxine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Levothyroxine Value by Countries (2014-2019)
• 7.2 Europe Levothyroxine Consumption by Type
• 7.3 Europe Levothyroxine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Levothyroxine by Countries
  • 8.1.1 Middle East & Africa Levothyroxine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Levothyroxine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Levothyroxine Consumption by Type
• 8.3 Middle East & Africa Levothyroxine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Levothyroxine Distributors
• 10.3 Levothyroxine Customer

11 Global Levothyroxine Market Forecast

• 11.1 Global Levothyroxine Consumption Forecast (2019-2024)
• 11.2 Global Levothyroxine Forecast by Regions
  • 11.2.1 Global Levothyroxine Forecast by Regions (2019-2024)
  • 11.2.2 Global Levothyroxine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Levothyroxine Forecast by Type
• 11.8 Global Levothyroxine Forecast by Application

12 Key Players Analysis

• 12.1 Abbott Ltd
  • 12.1.1 Company Details
  • 12.1.2 Levothyroxine Product Offered
  • 12.1.3 Abbott Ltd Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Abbott Ltd News
• 12.2 Alara Pharm (Sandoz)
  • 12.2.1 Company Details
  • 12.2.2 Levothyroxine Product Offered
  • 12.2.3 Alara Pharm (Sandoz) Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Alara Pharm (Sandoz) News
• 12.3 Forest (Actavis)
  • 12.3.1 Company Details
  • 12.3.2 Levothyroxine Product Offered
  • 12.3.3 Forest (Actavis) Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Forest (Actavis) News
• 12.4 Merck Serono
  • 12.4.1 Company Details
  • 12.4.2 Levothyroxine Product Offered
  • 12.4.3 Merck Serono Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Merck Serono News
• 12.5 Piramal Healthcare
  • 12.5.1 Company Details
  • 12.5.2 Levothyroxine Product Offered
  • 12.5.3 Piramal Healthcare Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Piramal Healthcare News
• 12.6 Mylan
  • 12.6.1 Company Details
  • 12.6.2 Levothyroxine Product Offered
  • 12.6.3 Mylan Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Mylan News
• 12.7 KING PHARMS R AND D
  • 12.7.1 Company Details
  • 12.7.2 Levothyroxine Product Offered
  • 12.7.3 KING PHARMS R AND D Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 KING PHARMS R AND D News
• 12.8 Jerome Stevens
  • 12.8.1 Company Details
  • 12.8.2 Levothyroxine Product Offered
  • 12.8.3 Jerome Stevens Levothyroxine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 Jerome Stevens News

13 Research Findings and Conclusion

Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.

Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body's energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.

Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.

At present, United States market is mainly occupied by own brands. The domestic enterprise technology still keeps leading level.
Technology advantage is a key factor for domestic enterprise to make up most shares.

According to this study, over the next five years the Levothyroxine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Levothyroxine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Levothyroxine market by product type, application, key manufacturers and key regions and countries.

This study considers the Levothyroxine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Slice in solid
In bottles for injection
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Chemist's shops
Other medical institutions

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Levothyroxine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Levothyroxine market by identifying its various subsegments.
Focuses on the key global Levothyroxine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Levothyroxine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Levothyroxine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.